sustain 6 trial semaglutide π SUSTAIN-6 (NEJM 2016) β the safety that became a landmark., In 3,297 patients with type 2 diabetes at high CV risk, reduced:, β’ 3-point MACE 26% (HR 0.74), β’ Nonfatal stroke 39% Semaglutide and Cardiovascular Outcomes in
Pay in 4 interest-free payments of $7.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 14 - Aug 19







:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)





















